GT Biopharma gets FDA clearance for investigator-sponsored IND of GTB-5550 in multiple myeloma, reports ~$11M cash funding operations into Q3 2027
https://finviz.com/stock?t=GTBP&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.